Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026)
Lifeward's (LFWD) quarterly Liabilities and Shareholders Equity came in at $35.0 million in Q2 2026, up 30.71% year-over-year from $26.8 million in Q2 2025, and up 4.73% quarter-over-quarter from $33.4 million in Q1 2026.
Analysis
Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Lifeward has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $35.0 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 30.71% year-over-year to $35.0 million; the TTM figure through Jun 2026 stood at $114.5 million (down 13.16% YoY), while the FY2025 annual figure was $22.9 million, down 24.89% from the prior year.
- Liabilities and Shareholders Equity came in at $35.0 million for Q2 2026 at Lifeward, up from $33.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.0 million in Q1 2022 to a low of $22.9 million in Q4 2025.
- Average Liabilities and Shareholders Equity over 5 years is $52.8 million, with a median of $53.1 million recorded in 2024.
- Year-over-year, Liabilities and Shareholders Equity tumbled 51.75% in 2024 and soared 30.71% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $74.2 million in 2022, then declined by 14.88% to $63.2 million in 2023, then slumped by 51.75% to $30.5 million in 2024, then slipped by 24.89% to $22.9 million in 2025, then surged by 52.84% to $35.0 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $35.0 million in Q2 2026, $33.4 million in Q1 2026, and $22.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Lifeward | 19.77 Mn | 10.32 Mn | 2.71 Mn | 35.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.00 Mn |
| Mar 31, 2026 | 33.42 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 28.81 Mn |
| Dec 31, 2024 | 30.49 Mn |
| Sep 30, 2024 | 45.77 Mn |
| Jun 30, 2024 | 50.98 Mn |
| Mar 31, 2024 | 55.22 Mn |
| Dec 31, 2023 | 63.19 Mn |
| Sep 30, 2023 | 69.22 Mn |
| Jun 30, 2023 | 65.81 Mn |
| Mar 31, 2023 | 68.98 Mn |
| Dec 31, 2022 | 74.24 Mn |
| Sep 30, 2022 | 80.77 Mn |
| Jun 30, 2022 | 85.80 Mn |
| Mar 31, 2022 | 90.00 Mn |
| Dec 31, 2021 | 94.75 Mn |
| Sep 30, 2021 | 98.72 Mn |